BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 25, 2002
View Archived Issues
New anti-H. pylori agents identified by American researchers
Read More
Dual DHFR/TS inhibitors with potential in cancer and opportunistic infections
Read More
Novel VEGFR inhibitors prepared and tested at Taisho
Read More
HE-2500, HE-2200 prove effective in animal models of multiple sclerosis
Read More
Immunomodulatory effects described for simvastatin in PBMCs from MS patients
Read More
New product for cancer heading for clinical testing at ProMetic
Read More
First nucleotide analogue for HBV approved by FDA
Read More
Worldwide development and marketing agreement for epothilone D in cancer
Read More
Forest withdraws NDA to amend and refile later this year
Read More
First Rigel compound enters clinical testing for allergic rhinitis
Read More
Potential new antidepressant presented by Faes in Toledo
Read More
Pharmacokinetics of components of AVP-923 examined in poor and extensive metabolizers
Read More
Candidate malaria vaccine emerges from research by Australian and U.S. scientists
Read More
Antibacterial quinolones in early development at Pharmacia
Read More
Kaken identifies VLA-4 antagonists
Read More
Fujisawa and Pharmagenesis collaborate on triptolide derivatives
Read More
Benefits of tiotropium in COPD become evident upon withdrawal
Read More
FDA issues approvable letter for Metvix
Read More
Trospium meets endpoints in phase III overactive bladder trial
Read More
Tarceva receives second fast track designation
Read More
Phase I cleared for Islet Neogenesis Therapy
Read More
Safety data for omalizumab reported at the 2002 ERS congress
Read More
Clopidogrel approved in E.U. for patients with acute coronary syndrome
Read More
Biotica expands macrolide antiinfective research collaboration with Pfizer
Read More
